X-47201619-C-G

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_003334.4(UBA1):​c.811+9C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.99 ( 37872 hom., 32775 hem., cov: 23)
Exomes 𝑓: 0.98 ( 355394 hom. 356236 hem. )
Failed GnomAD Quality Control

Consequence

UBA1
NM_003334.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.363
Variant links:
Genes affected
UBA1 (HGNC:12469): (ubiquitin like modifier activating enzyme 1) The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant X-47201619-C-G is Benign according to our data. Variant chrX-47201619-C-G is described in ClinVar as [Benign]. Clinvar id is 368331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-47201619-C-G is described in Lovd as [Benign].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UBA1NM_003334.4 linkc.811+9C>G intron_variant Intron 8 of 25 ENST00000335972.11 NP_003325.2 P22314-1A0A024R1A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UBA1ENST00000335972.11 linkc.811+9C>G intron_variant Intron 8 of 25 1 NM_003334.4 ENSP00000338413.6 P22314-1
UBA1ENST00000377351.8 linkc.811+9C>G intron_variant Intron 8 of 25 1 ENSP00000366568.4 P22314-1
UBA1ENST00000442035.5 linkc.*9C>G downstream_gene_variant 5 ENSP00000389583.1 Q5JRS0
UBA1ENST00000412206.5 linkc.*8C>G downstream_gene_variant 5 ENSP00000415033.1 Q5JRR9

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
109502
AN:
111040
Hom.:
37880
Cov.:
23
AF XY:
0.986
AC XY:
32711
AN XY:
33192
FAILED QC
Gnomad AFR
AF:
0.997
Gnomad AMI
AF:
0.909
Gnomad AMR
AF:
0.990
Gnomad ASJ
AF:
0.980
Gnomad EAS
AF:
0.953
Gnomad SAS
AF:
0.934
Gnomad FIN
AF:
0.996
Gnomad MID
AF:
0.987
Gnomad NFE
AF:
0.984
Gnomad OTH
AF:
0.983
GnomAD3 exomes
AF:
0.980
AC:
178301
AN:
182014
Hom.:
55551
AF XY:
0.976
AC XY:
65197
AN XY:
66816
show subpopulations
Gnomad AFR exome
AF:
0.998
Gnomad AMR exome
AF:
0.993
Gnomad ASJ exome
AF:
0.981
Gnomad EAS exome
AF:
0.953
Gnomad SAS exome
AF:
0.933
Gnomad FIN exome
AF:
0.995
Gnomad NFE exome
AF:
0.984
Gnomad OTH exome
AF:
0.978
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.983
AC:
1078778
AN:
1097948
Hom.:
355394
Cov.:
45
AF XY:
0.980
AC XY:
356236
AN XY:
363330
show subpopulations
Gnomad4 AFR exome
AF:
0.998
Gnomad4 AMR exome
AF:
0.992
Gnomad4 ASJ exome
AF:
0.982
Gnomad4 EAS exome
AF:
0.972
Gnomad4 SAS exome
AF:
0.934
Gnomad4 FIN exome
AF:
0.994
Gnomad4 NFE exome
AF:
0.985
Gnomad4 OTH exome
AF:
0.979
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.986
AC:
109552
AN:
111094
Hom.:
37872
Cov.:
23
AF XY:
0.986
AC XY:
32775
AN XY:
33256
show subpopulations
Gnomad4 AFR
AF:
0.997
Gnomad4 AMR
AF:
0.990
Gnomad4 ASJ
AF:
0.980
Gnomad4 EAS
AF:
0.953
Gnomad4 SAS
AF:
0.935
Gnomad4 FIN
AF:
0.996
Gnomad4 NFE
AF:
0.984
Gnomad4 OTH
AF:
0.978
Alfa
AF:
0.980
Hom.:
8268
Bravo
AF:
0.987

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Infantile-onset X-linked spinal muscular atrophy Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 05, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 98% of patients studied by a panel of primary immunodeficiencies. Number of patients: 93. Only high quality variants are reported. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 16, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.7
DANN
Benign
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4239964; hg19: chrX-47061018; API